New data from the Primary Rituximab And Maintenance study provide the strongest support for the use of rituximab maintenance in patients with follicular lymphoma. However, further considerations ...

Rituximab Maintenance Therapy Improves Survival In Patients With Relapsed Follicular Lymphoma Date: February 10, 2009 Source: Journal of the National Cancer Institute ...

Patients with follicular lymphoma, a slow-growing common type of non-Hodgkin's lymphoma, who are given 2 years of rituximab-maintenance therapy after immunochemotherapy, have significantly better ...

Two hundred seventy patients with untreated, relapsed, stable, or chemotherapy-resistant follicular lymphoma were treated with four doses of rituximab monotherapy in weekly intervals (375 mg/m ...

ATLANTA -- Patients with newly diagnosed low-burden follicular lymphoma (FL) in remission avoided chemotherapy significantly longer if they received maintenance rituximab (Rituxan) instead of ...

Patients with relapsed or refractory follicular lymphoma who continue on maintenance rituximab therapy after chemotherapy have better overall survival than patients who do not receive this ...

The best initial treatment strategy for asymptomatic, advanced-stage nonbulky follicular lymphoma is "not clear," according to an editorial published in the April edition of Lancet Oncology. Watch ...

Pettengel et al 1 elegantly describe a randomized trial assessing the efficacy and safety of rituximab as in vivo purging before transplantation and as maintenance treatment after high-dose ...

Treatment-naive patients with advanced follicular lymphoma who received a combination of rituximab plus lenalidomide appeared to have similar outcomes as patients treated with rituximab and ...

RITUXAN (rituximab) 10mg/mL solution for IV infusion by Genentech Genentech announced that the FDA has approved Rituxan (rituximab) as maintenance treatment for patients with advanced follicular ...

New data from the Primary Rituximab And Maintenance study provide the strongest support for the use of rituximab maintenance in patients with follicular lymphoma. However, further considerations ...